These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 23303872)

  • 1. Docosahexaenoic acid attenuates hepatic inflammation, oxidative stress, and fibrosis without decreasing hepatosteatosis in a Ldlr(-/-) mouse model of western diet-induced nonalcoholic steatohepatitis.
    Depner CM; Philbrick KA; Jump DB
    J Nutr; 2013 Mar; 143(3):315-23. PubMed ID: 23303872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Docosahexaenoic acid blocks progression of western diet-induced nonalcoholic steatohepatitis in obese Ldlr-/- mice.
    Lytle KA; Wong CP; Jump DB
    PLoS One; 2017; 12(4):e0173376. PubMed ID: 28422962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Menhaden oil decreases high-fat diet-induced markers of hepatic damage, steatosis, inflammation, and fibrosis in obese Ldlr-/- mice.
    Depner CM; Torres-Gonzalez M; Tripathy S; Milne G; Jump DB
    J Nutr; 2012 Aug; 142(8):1495-503. PubMed ID: 22739374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A metabolomic analysis of omega-3 fatty acid-mediated attenuation of western diet-induced nonalcoholic steatohepatitis in LDLR-/- mice.
    Depner CM; Traber MG; Bobe G; Kensicki E; Bohren KM; Milne G; Jump DB
    PLoS One; 2013; 8(12):e83756. PubMed ID: 24358308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential for dietary ω-3 fatty acids to prevent nonalcoholic fatty liver disease and reduce the risk of primary liver cancer.
    Jump DB; Depner CM; Tripathy S; Lytle KA
    Adv Nutr; 2015 Nov; 6(6):694-702. PubMed ID: 26567194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is Western Diet-Induced Nonalcoholic Steatohepatitis in Ldlr-/- Mice Reversible?
    Lytle KA; Jump DB
    PLoS One; 2016; 11(1):e0146942. PubMed ID: 26761430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Docosahexaenoic acid attenuates Western diet-induced hepatic fibrosis in Ldlr-/- mice by targeting the TGFβ-Smad3 pathway.
    Lytle KA; Depner CM; Wong CP; Jump DB
    J Lipid Res; 2015 Oct; 56(10):1936-46. PubMed ID: 26315048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipidomic and transcriptomic analysis of western diet-induced nonalcoholic steatohepatitis (NASH) in female Ldlr -/- mice.
    Garcia-Jaramillo M; Spooner MH; Löhr CV; Wong CP; Zhang W; Jump DB
    PLoS One; 2019; 14(4):e0214387. PubMed ID: 30943218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different Effects of Eicosapentaenoic and Docosahexaenoic Acids on Atherogenic High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice.
    Suzuki-Kemuriyama N; Matsuzaka T; Kuba M; Ohno H; Han SI; Takeuchi Y; Isaka M; Kobayashi K; Iwasaki H; Yatoh S; Suzuki H; Miyajima K; Nakae D; Yahagi N; Nakagawa Y; Sone H; Yamada N; Shimano H
    PLoS One; 2016; 11(6):e0157580. PubMed ID: 27333187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of dietary fat on the development of non-alcoholic fatty liver disease in Ldlr-/- mice.
    Jump DB; Depner CM; Tripathy S; Lytle KA
    Proc Nutr Soc; 2016 Feb; 75(1):1-9. PubMed ID: 26282529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction in dietary omega-6 polyunsaturated fatty acids: eicosapentaenoic acid plus docosahexaenoic acid ratio minimizes atherosclerotic lesion formation and inflammatory response in the LDL receptor null mouse.
    Wang S; Wu D; Matthan NR; Lamon-Fava S; Lecker JL; Lichtenstein AH
    Atherosclerosis; 2009 May; 204(1):147-55. PubMed ID: 18842266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Lipidomic Analysis of Docosahexaenoic Acid (22:6, ω3) Mediated Attenuation of Western Diet Induced Nonalcoholic Steatohepatitis in Male
    García-Jaramillo M; Lytle KA; Spooner MH; Jump DB
    Metabolites; 2019 Oct; 9(11):. PubMed ID: 31661783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of docosahexaenoic acid in an experimental rat model of nonalcoholic steatohepatitis.
    Takayama F; Nakamoto K; Totani N; Yamanushi T; Kabuto H; Kaneyuki T; Mankura M
    J Oleo Sci; 2010; 59(8):407-14. PubMed ID: 20625232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time course of western diet (WD) induced nonalcoholic steatohepatitis (NASH) in female and male Ldlr-/- mice.
    Spooner MH; Garcia-Jaramillo M; Apperson KD; Löhr CV; Jump DB
    PLoS One; 2023; 18(10):e0292432. PubMed ID: 37819925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eicosapentaenoic and docosahexaenoic acid-enriched high fat diet delays the development of fatty liver in mice.
    Soni NK; Nookaew I; Sandberg AS; Gabrielsson BG
    Lipids Health Dis; 2015 Jul; 14():74. PubMed ID: 26193881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Transgenic Camelina sativa Seed Oil Effectively Replaces Fish Oil as a Dietary Source of Eicosapentaenoic Acid in Mice.
    Tejera N; Vauzour D; Betancor MB; Sayanova O; Usher S; Cochard M; Rigby N; Ruiz-Lopez N; Menoyo D; Tocher DR; Napier JA; Minihane AM
    J Nutr; 2016 Feb; 146(2):227-35. PubMed ID: 26791554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rosiglitazone attenuates age- and diet-associated nonalcoholic steatohepatitis in male low-density lipoprotein receptor knockout mice.
    Gupte AA; Liu JZ; Ren Y; Minze LJ; Wiles JR; Collins AR; Lyon CJ; Pratico D; Finegold MJ; Wong ST; Webb P; Baxter JD; Moore DD; Hsueh WA
    Hepatology; 2010 Dec; 52(6):2001-11. PubMed ID: 20938947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptor-deficient mice.
    Subramanian S; Goodspeed L; Wang S; Kim J; Zeng L; Ioannou GN; Haigh WG; Yeh MM; Kowdley KV; O'Brien KD; Pennathur S; Chait A
    J Lipid Res; 2011 Sep; 52(9):1626-35. PubMed ID: 21690266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fucoxanthin inhibits hepatic oxidative stress, inflammation, and fibrosis in diet-induced nonalcoholic steatohepatitis model mice.
    Takatani N; Kono Y; Beppu F; Okamatsu-Ogura Y; Yamano Y; Miyashita K; Hosokawa M
    Biochem Biophys Res Commun; 2020 Jul; 528(2):305-310. PubMed ID: 32475638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocyte Nicotinamide Adenine Dinucleotide Phosphate Reduced Oxidase 4 Regulates Stress Signaling, Fibrosis, and Insulin Sensitivity During Development of Steatohepatitis in Mice.
    Bettaieb A; Jiang JX; Sasaki Y; Chao TI; Kiss Z; Chen X; Tian J; Katsuyama M; Yabe-Nishimura C; Xi Y; Szyndralewiez C; Schröder K; Shah A; Brandes RP; Haj FG; Török NJ
    Gastroenterology; 2015 Aug; 149(2):468-80.e10. PubMed ID: 25888330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.